Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Dementia
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Werner, P.
Right arrow Articles by Davidson, M.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Family Caregivers’ Willingness to Pay for Drugs Indicated for the Treatment of Alzheimer’s Disease

An economic or psychological model?

Perla Werner

University of Haifawernerp{at}netvision.net.il

Michal Schnaider-Beeri

Sheva Medical Centremichalsb{at}hotmail.com

Judith Aharon

Rambam Medical Centerjaharon{at}rambam.health.gov.il

Michael Davidson

Sheva Medical Centre/Sackler Medical School, Tel Aviv Universitydavidso{at}netvision.net.il

The aim of the present study was to examine the willingness of family members caring for patients with probable Alzheimer’s Disease (AD) to pay for drug treatment, using the contingent valuation technique and the theory of planned behavior. A sample of 220 family members (68.2% F, mean age = 62.3; 59.8% spouses and the rest children) were interviewed regarding their willingness to pay (WTP) for drug treatment, their attitudes, normative expectations of significant others and perceived behavioral control. The mean WTP for drug treatment was estimated at about 60–80% of the retail price of the drug at the time of the study. Participants were willing to pay a significantly higher price when provided with information regarding side effects. Including psychological determinants (especially regarding affordability and normative expectations of significant others) improved an economic model. The understanding of decision-making processes in the framework of dementia should be expanded to include economic and psychological determinants.

Key Words: Alzheimer’s disease (AD) • attitudes • decision-making • drug treatment • willingness to pay (WTP)

Dementia, Vol. 1, No. 1, 59-74 (2002)
DOI: 10.1177/147130120200100109
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 DementiaHome page
M. Oremus and J.-E. Tarride
A systematic review of the use of contingent valuation in Alzheimer's disease research
Dementia, November 1, 2008; 7(4): 461 - 480.
[Abstract] [PDF]